USPTO 2015–2025 USPTO PatentsView US Corporation

Haemonetics Corporation

USPTO PatentsView assignee record - 61 granted patents across 22 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

23.8

Avg claims per patent

+77%

5-year filing velocity

The verdict

Haemonetics holds 61 US patents across 22 technology areas, rank #5,593 of 50,000 tracked assignees.

#5,593
of 50,000 US assignees by volume: Top 11%
by Innovation Score (52.1/100): 23.8
avg claims per patent: +77%
filing velocity, last 5 yrs

Portfolio overview

Haemonetics Corporation has been granted 61 US utility patents between 2015 and 2025, placing Haemonetics Corporation at rank #5,593 across all assignees tracked by PlainPatent. This portfolio spans 22 distinct Cooperative Patent Classification (CPC) subclasses, averaging 23.8 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, Haemonetics Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Haemonetics sits between Groz-beckert KG (61 patents, rank #5,589) and Inpria Corporation (61 patents, rank #5,597) - the closest US assignees by grant volume. The composite Innovation Score of 52.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 39 grants, compared with 22 in the 2015–2019 window, a +77% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Haemonetics Corporation's 23.8 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 22 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Haemonetics Corporation against peers pursuing similar technology classes.

Groz-beckert KG

61
Gen Digital

61
Hydac Filtertechn…

61
Hydro-quÉBEC

61
Harbin Engineerin…

61
Infinidat

61
Innovaplant Zierp…

61
Inpria

61
Haemonetics ◀

61

What this shows Haemonetics holds 61 patents at rank #5,593, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Haemonetics

By rank, the assignees closest to #5,593 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media INTO)

Other assignees with the most granted patents in Haemonetics's primary technology class.

Haemonetics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

52 Top 11% higher than 89% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Haemonetics Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	4.9%
2016	8	13.1%
2017	5	8.2%
2018	2	3.3%
2019	4	6.6%
2020	7	11.5%
2021	8	13.1%
2022	2	3.3%
2023	11	18.0%
2024	7	11.5%
2025	4	6.6%

Which technologies does Haemonetics Corporation patent most?

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 37

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 24

B04B - CENTRIFUGES 11

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 7

B01D - SEPARATION 7

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 5

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 4

A61J - CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE 4

G01L - MEASURING FORCE, STRESS, TORQUE, WORK, MECHANICAL POWER, MECHANICAL EFFICIENCY, OR FLUID PRESSURE 3

F16M - FRAMES, CASINGS OR BEDS OF ENGINES, MACHINES OR APPARATUS, NOT SPECIFIC TO ENGINES, MACHINES OR APPARATUS PROVIDED FOR ELSEWHERE; STANDS; SUPPORTS 3

G06K - GRAPHICAL DATA READING ; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS 2

B65D - CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 2

B81B - MICROSTRUCTURAL DEVICES OR SYSTEMS, e.g. MICROMECHANICAL DEVICES 1

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 1

G01R - MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES 1

Top 15 of 22 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Multi-domain

Claim Depth Complex

Velocity Accelerating

Where it ranks

Overall rank by patents

#5,593

Across all tracked assignees

Innovation Score

52.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Haemonetics Corporation hold?

Haemonetics Corporation holds 61 US granted patents filed between 2015 and 2025, spanning 22 technology areas.

What is Haemonetics Corporation's Innovation Score?

Haemonetics Corporation has an Innovation Score of 52.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Haemonetics Corporation focus on?

Haemonetics Corporation's top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 37 patents. The company has filed patents in 22 CPC subclasses total.

Is Haemonetics Corporation's patent filing rate increasing or decreasing?

Haemonetics Corporation's recent filing velocity is +77% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Haemonetics Corporation's patents?

Haemonetics Corporation's patents average 23.8 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the Haemonetics Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Haemonetics's 61 grants land it in the top 11% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Haemonetics ranks #5,593 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61M - see who else leads that technology area. A61M leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.